Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.46 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Zhengye Biotechnology Holding (ZYBT) Accounts Payables (2023 - 2025)

Updated

Zhengye Biotechnology Holding's Accounts Payables was $6.21 million in the quarter ended Dec 31, 2025, up 3.8% from $5.98 million a year earlier.

Analysis

Zhengye Biotechnology Holding (ZYBT) Accounts Payables (2023 - 2025) Analysis & Trends

As of Dec 31, 2025, Accounts Payables at Zhengye Biotechnology Holding came in at $6.3 million, up 7.0% from the prior year.

  • In earlier years, Accounts Payables was $5.89 million in the year ended Dec 31, 2024 (-8.9%) and $6.46 million in the year ended Dec 31, 2023.
  • The figure for the quarter ended Dec 31, 2025 marks the highest quarterly Accounts Payables since the quarter ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 9.32 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 33.30 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 3.83 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 22.89 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 674.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 4.58 Bn
10 Zhengye Biotechnology Holding 70.08 Mn 58.36 Mn - 6.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.29 Mn
Jun 30, 2025 5.98 Mn
Dec 31, 2024 5.89 Mn
Dec 31, 2023 6.42 Mn
API Access

Zhengye Biotechnology Holding Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=ZYBT&period=max&api_key=YOUR_API_KEY